HCPs and key opinion leaders (KOLs) have always been central to the success of new therapies, shaping how innovations reach patients and influencing the trajectory of scientific understanding within ...
In experimental settings, CB1 agonists like THC do alter sleep architecture, shifting NREM and REM balance and restructuring intermediate sleep stages.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results